BackgroundThis study was performed to determine the factors associated with long-term oral hypoglycemic agent (OHA) responsiveness in Korean type 2 diabetic patients.MethodsTwo groups of patients were selected among the type 2 diabetic patients who were followed for more than two years at a university hospital diabetes clinic. The OHA responsive group consisted of 197 patients whose HbA1c levels were maintained at ≤7% with OHA for more than two years. The OHA failure group consisted of 180 patients whose HbA1c levels were >8% in spite of optimal combined OHA therapy or patients who required insulin therapy within the two years of the study.ResultsThe OHA failure group had higher baseline values of fasting and postprandial glucose, HbA1c, an...
<div><p>We investigated differences in the achievement of glycemic control among newly diagnosed typ...
AIMS: To evaluate factors associated with reaching or not reaching target glycated haemoglobin (HbA1...
AIM: To investigate whether the change in glycated albumin 3 weeks after initiating anti-diabetes tr...
Hypoglycemia is one of the most important complications of diabetes treatment and it becomes an obst...
<div><p>The objective of this study was to explore predictors, including social factors, lifestyle f...
Little is known about the relationships between patient factors and the antihyperglycemic agents tha...
Objectives: This study was conducted to determine factors related to glycemic control among Korean p...
The objective of this study was to explore predictors, including social factors, lifestyle fac-tors,...
Background: The purpose of this study was to evaluate change in glycosylated hemoglobin (HbA1c), sid...
Background: Diabetes mellitus requires aggressive long-term therapy to decrease morbidity and mortal...
The objective of this study was to explore predictors, including social factors, lifestyle factors, ...
Aims: To assess factors associated with Prolonged Inaction (PI) in insulin-naive patients with Type ...
AIMS: Hypoglycemia is a limiting factor for achieving stringent glycemic control in diabetes. This s...
Background: The aim of the present study was to identify demographic and treatment factors that were...
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands. bwo@sin...
<div><p>We investigated differences in the achievement of glycemic control among newly diagnosed typ...
AIMS: To evaluate factors associated with reaching or not reaching target glycated haemoglobin (HbA1...
AIM: To investigate whether the change in glycated albumin 3 weeks after initiating anti-diabetes tr...
Hypoglycemia is one of the most important complications of diabetes treatment and it becomes an obst...
<div><p>The objective of this study was to explore predictors, including social factors, lifestyle f...
Little is known about the relationships between patient factors and the antihyperglycemic agents tha...
Objectives: This study was conducted to determine factors related to glycemic control among Korean p...
The objective of this study was to explore predictors, including social factors, lifestyle fac-tors,...
Background: The purpose of this study was to evaluate change in glycosylated hemoglobin (HbA1c), sid...
Background: Diabetes mellitus requires aggressive long-term therapy to decrease morbidity and mortal...
The objective of this study was to explore predictors, including social factors, lifestyle factors, ...
Aims: To assess factors associated with Prolonged Inaction (PI) in insulin-naive patients with Type ...
AIMS: Hypoglycemia is a limiting factor for achieving stringent glycemic control in diabetes. This s...
Background: The aim of the present study was to identify demographic and treatment factors that were...
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands. bwo@sin...
<div><p>We investigated differences in the achievement of glycemic control among newly diagnosed typ...
AIMS: To evaluate factors associated with reaching or not reaching target glycated haemoglobin (HbA1...
AIM: To investigate whether the change in glycated albumin 3 weeks after initiating anti-diabetes tr...